Behind the deal: AngioDynamics acquired a laser startup so it can take on industry giants Medtronic and Boston Scientific


AngioDynamics CEO Jim Clemmer has spent the past two years shedding low-margin products from the Latham company's portfolio, replacing them with higher-margin emerging technology.

Previous New Cambridge biotech Korro aims to develop a reversible form of gene editing
Next Growth concerns on metro Denver’s fringe spark effort to recall Elizabeth’s entire elected government